The global Decentralized Clinical Trials (DCTs) market was valued at US$ 8281 million in 2023 and is anticipated to reach US$ 21480 million by 2030, witnessing a CAGR of 14.8% during the forecast period 2024-2030.

Decentralized Clinical Trials (DCTs) Market

The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model. Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.

The decentralized clinical trials (DCT) market is driven by the growing need for patient-centric trial designs that improve accessibility and convenience. By leveraging technology such as telemedicine, wearables, and remote monitoring, DCTs allow patients to participate from their homes, reducing the burden of travel and time commitments. This not only enhances patient recruitment and retention rates but also enables trials to include more diverse and geographically dispersed populations, ultimately accelerating the drug development process. However, a significant challenge in the decentralized clinical trials market is the integration of complex digital tools and data management systems. Ensuring the seamless and secure transfer of patient data across various platforms requires significant investment in infrastructure and poses privacy concerns. Additionally, regulatory frameworks for DCTs are still evolving, and inconsistencies in approval processes across regions can create barriers for global trial implementation. Ensuring patient compliance and maintaining trial integrity in a remote setting also add layers of complexity to trial management.

Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%. North America is the largest sales region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.

This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trials (DCTs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trials (DCTs).

The Decentralized Clinical Trials (DCTs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Decentralized Clinical Trials (DCTs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Decentralized Clinical Trials (DCTs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Decentralized Clinical Trials (DCTs) Market Report

Report Metric	Details
Report Name	Decentralized Clinical Trials (DCTs) Market
Accounted market size in 2023	US$ 8281 million
Forecasted market size in 2030	US$ 21480 million
CAGR	14.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Interventional Observational Expanded Access
Segment by Application	Oncology Cardiovascular Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health, Clinical Ink, Medable, Science 37
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Decentralized Clinical Trials (DCTs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Decentralized Clinical Trials (DCTs) Market growing?

Ans: The Decentralized Clinical Trials (DCTs) Market witnessing a CAGR of 14.8% during the forecast period 2024-2030.

What is the Decentralized Clinical Trials (DCTs) Market size in 2030?

Ans: The Decentralized Clinical Trials (DCTs) Market size in 2030 will be US$ 21480 million.

What is the market share of major companies in Decentralized Clinical Trials (DCTs) Market?

Ans: Global top five manufacturers hold a share over 45%.

What is the Decentralized Clinical Trials (DCTs) Market share by type?

Ans: In terms of product, Interventional is the largest segment, with a share over 45%.

Who are the main players in the Decentralized Clinical Trials (DCTs) Market report?

Ans: The main players in the Decentralized Clinical Trials (DCTs) Market are Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health, Clinical Ink, Medable, Science 37

What are the Application segmentation covered in the Decentralized Clinical Trials (DCTs) Market report?

Ans: The Applications covered in the Decentralized Clinical Trials (DCTs) Market report are Oncology, Cardiovascular, Others

What are the Type segmentation covered in the Decentralized Clinical Trials (DCTs) Market report?

Ans: The Types covered in the Decentralized Clinical Trials (DCTs) Market report are Interventional, Observational, Expanded Access

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Interventional

1.2.3 Observational

1.2.4 Expanded Access

1.3 Market by Application

1.3.1 Global Decentralized Clinical Trials (DCTs) Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2019-2030)

2.2 Global Decentralized Clinical Trials (DCTs) Growth Trends by Region

2.2.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Decentralized Clinical Trials (DCTs) Historic Market Size by Region (2019-2024)

2.2.3 Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2025-2030)

2.3 Decentralized Clinical Trials (DCTs) Market Dynamics

2.3.1 Decentralized Clinical Trials (DCTs) Industry Trends

2.3.2 Decentralized Clinical Trials (DCTs) Market Drivers

2.3.3 Decentralized Clinical Trials (DCTs) Market Challenges

2.3.4 Decentralized Clinical Trials (DCTs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue

3.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2019-2024)

3.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2019-2024)

3.2 Global Decentralized Clinical Trials (DCTs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Decentralized Clinical Trials (DCTs) Revenue

3.4 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio

3.4.1 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trials (DCTs) Revenue in 2023

3.5 Global Key Players of Decentralized Clinical Trials (DCTs) Head office and Area Served

3.6 Global Key Players of Decentralized Clinical Trials (DCTs), Product and Application

3.7 Global Key Players of Decentralized Clinical Trials (DCTs), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Decentralized Clinical Trials (DCTs) Breakdown Data by Type

4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2019-2024)

4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2025-2030)

5 Decentralized Clinical Trials (DCTs) Breakdown Data by Application

5.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2019-2024)

5.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Decentralized Clinical Trials (DCTs) Market Size (2019-2030)

6.2 North America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2019-2024)

6.4 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Decentralized Clinical Trials (DCTs) Market Size (2019-2030)

7.2 Europe Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2019-2024)

7.4 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size (2019-2030)

8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2019-2024)

8.4 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Decentralized Clinical Trials (DCTs) Market Size (2019-2030)

9.2 Latin America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2019-2024)

9.4 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size (2019-2030)

10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2019-2024)

10.4 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medidata

11.1.1 Medidata Company Details

11.1.2 Medidata Business Overview

11.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction

11.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.1.5 Medidata Recent Development

11.2 IQVIA

11.2.1 IQVIA Company Details

11.2.2 IQVIA Business Overview

11.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction

11.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.2.5 IQVIA Recent Development

11.3 Labcorp

11.3.1 Labcorp Company Details

11.3.2 Labcorp Business Overview

11.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction

11.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.3.5 Labcorp Recent Development

11.4 PRA Health Sciences

11.4.1 PRA Health Sciences Company Details

11.4.2 PRA Health Sciences Business Overview

11.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction

11.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.4.5 PRA Health Sciences Recent Development

11.5 Parexel

11.5.1 Parexel Company Details

11.5.2 Parexel Business Overview

11.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction

11.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.5.5 Parexel Recent Development

11.6 ICON

11.6.1 ICON Company Details

11.6.2 ICON Business Overview

11.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction

11.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.6.5 ICON Recent Development

11.7 Oracle

11.7.1 Oracle Company Details

11.7.2 Oracle Business Overview

11.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction

11.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.7.5 Oracle Recent Development

11.8 CRF Health

11.8.1 CRF Health Company Details

11.8.2 CRF Health Business Overview

11.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction

11.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.8.5 CRF Health Recent Development

11.9 Clinical Ink

11.9.1 Clinical Ink Company Details

11.9.2 Clinical Ink Business Overview

11.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction

11.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.9.5 Clinical Ink Recent Development

11.10 Medable

11.10.1 Medable Company Details

11.10.2 Medable Business Overview

11.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction

11.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.10.5 Medable Recent Development

11.11 Science 37

11.11.1 Science 37 Company Details

11.11.2 Science 37 Business Overview

11.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction

11.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024)

11.11.5 Science 37 Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Interventional

Table 3. Key Players of Observational

Table 4. Key Players of Expanded Access

Table 5. Global Decentralized Clinical Trials (DCTs) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Decentralized Clinical Trials (DCTs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Decentralized Clinical Trials (DCTs) Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Decentralized Clinical Trials (DCTs) Market Share by Region (2019-2024)

Table 9. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Decentralized Clinical Trials (DCTs) Market Share by Region (2025-2030)

Table 11. Decentralized Clinical Trials (DCTs) Market Trends

Table 12. Decentralized Clinical Trials (DCTs) Market Drivers

Table 13. Decentralized Clinical Trials (DCTs) Market Challenges

Table 14. Decentralized Clinical Trials (DCTs) Market Restraints

Table 15. Global Decentralized Clinical Trials (DCTs) Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Decentralized Clinical Trials (DCTs) Market Share by Players (2019-2024)

Table 17. Global Top Decentralized Clinical Trials (DCTs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trials (DCTs) as of 2023)

Table 18. Ranking of Global Top Decentralized Clinical Trials (DCTs) Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Decentralized Clinical Trials (DCTs) Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Decentralized Clinical Trials (DCTs), Headquarters and Area Served

Table 21. Global Key Players of Decentralized Clinical Trials (DCTs), Product and Application

Table 22. Global Key Players of Decentralized Clinical Trials (DCTs), Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Decentralized Clinical Trials (DCTs) Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2019-2024)

Table 26. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2025-2030)

Table 28. Global Decentralized Clinical Trials (DCTs) Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2019-2024)

Table 30. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2025-2030)

Table 32. North America Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Decentralized Clinical Trials (DCTs) Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Decentralized Clinical Trials (DCTs) Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2025-2030) & (US$ Million)

Table 47. Medidata Company Details

Table 48. Medidata Business Overview

Table 49. Medidata Decentralized Clinical Trials (DCTs) Product

Table 50. Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 51. Medidata Recent Development

Table 52. IQVIA Company Details

Table 53. IQVIA Business Overview

Table 54. IQVIA Decentralized Clinical Trials (DCTs) Product

Table 55. IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 56. IQVIA Recent Development

Table 57. Labcorp Company Details

Table 58. Labcorp Business Overview

Table 59. Labcorp Decentralized Clinical Trials (DCTs) Product

Table 60. Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 61. Labcorp Recent Development

Table 62. PRA Health Sciences Company Details

Table 63. PRA Health Sciences Business Overview

Table 64. PRA Health Sciences Decentralized Clinical Trials (DCTs) Product

Table 65. PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 66. PRA Health Sciences Recent Development

Table 67. Parexel Company Details

Table 68. Parexel Business Overview

Table 69. Parexel Decentralized Clinical Trials (DCTs) Product

Table 70. Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 71. Parexel Recent Development

Table 72. ICON Company Details

Table 73. ICON Business Overview

Table 74. ICON Decentralized Clinical Trials (DCTs) Product

Table 75. ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 76. ICON Recent Development

Table 77. Oracle Company Details

Table 78. Oracle Business Overview

Table 79. Oracle Decentralized Clinical Trials (DCTs) Product

Table 80. Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 81. Oracle Recent Development

Table 82. CRF Health Company Details

Table 83. CRF Health Business Overview

Table 84. CRF Health Decentralized Clinical Trials (DCTs) Product

Table 85. CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 86. CRF Health Recent Development

Table 87. Clinical Ink Company Details

Table 88. Clinical Ink Business Overview

Table 89. Clinical Ink Decentralized Clinical Trials (DCTs) Product

Table 90. Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 91. Clinical Ink Recent Development

Table 92. Medable Company Details

Table 93. Medable Business Overview

Table 94. Medable Decentralized Clinical Trials (DCTs) Product

Table 95. Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 96. Medable Recent Development

Table 97. Science 37 Company Details

Table 98. Science 37 Business Overview

Table 99. Science 37 Decentralized Clinical Trials (DCTs) Product

Table 100. Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2019-2024) & (US$ Million)

Table 101. Science 37 Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Decentralized Clinical Trials (DCTs) Picture

Figure 2. Global Decentralized Clinical Trials (DCTs) Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Decentralized Clinical Trials (DCTs) Market Share by Type: 2023 VS 2030

Figure 4. Interventional Features

Figure 5. Observational Features

Figure 6. Expanded Access Features

Figure 7. Global Decentralized Clinical Trials (DCTs) Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Decentralized Clinical Trials (DCTs) Market Share by Application: 2023 VS 2030

Figure 9. Oncology Case Studies

Figure 10. Cardiovascular Case Studies

Figure 11. Others Case Studies

Figure 12. Decentralized Clinical Trials (DCTs) Report Years Considered

Figure 13. Global Decentralized Clinical Trials (DCTs) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Decentralized Clinical Trials (DCTs) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Decentralized Clinical Trials (DCTs) Market Share by Region: 2023 VS 2030

Figure 16. Global Decentralized Clinical Trials (DCTs) Market Share by Players in 2023

Figure 17. Global Top Decentralized Clinical Trials (DCTs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trials (DCTs) as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Decentralized Clinical Trials (DCTs) Revenue in 2023

Figure 19. North America Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Decentralized Clinical Trials (DCTs) Market Share by Country (2019-2030)

Figure 21. United States Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Decentralized Clinical Trials (DCTs) Market Share by Country (2019-2030)

Figure 25. Germany Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Share by Region (2019-2030)

Figure 33. China Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Decentralized Clinical Trials (DCTs) Market Share by Country (2019-2030)

Figure 41. Mexico Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Share by Country (2019-2030)

Figure 45. Turkey Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Medidata Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 49. IQVIA Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 50. Labcorp Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 51. PRA Health Sciences Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 52. Parexel Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 53. ICON Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 54. Oracle Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 55. CRF Health Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 56. Clinical Ink Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 57. Medable Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 58. Science 37 Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions